| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |